CRISPR and artificial intelligence - Medizinonline

The combination of precise genome editing using CRISPR and AI-supported modeling of complex CNS damage marks a paradigm shift in neuroregeneration. Adaptive, closed therapy loops are designed to address multiple molecular and cellular barriers simultaneously.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Dr. Ulf Blanke

Publikation

InFo NEUROLOGIE & PSYCHIATRIE

Related Topics

Previous Article

Asbestos victims

Federal Council has decided to amend the UVG

MASLD/MASH

Drug therapy options on the rise: spectacular evidence

You May Also Like

4 min

Psoriasis and metabolic comorbidities: new study data

GLP-1RAs showed a valuable dual benefit

5 min

Heart failure: combination of four as "Guideline-Directed Medical Therapy"

Standard established at HFrEF with individual nuances

7 min

Chronic inflammation as a driver of ageing

Immunosenescence and inflammaging

8 min

Evidence, limitations and practical implications

Phytotherapy for anxiety disorders

3 min

Case report: Hiccups after ketoacidosis

Nebulized lidocaine brings relief

6 min

Hidradenitis suppurativa: biologics reduce inflammatory processes

Treatment recommendations depend on the severity and inflammatory activity

7 min

Dizziness as a leading symptom: new consensus paper

Current recommendations for handling in everyday practice

- Education
- General Internal Medicine
- Neurology
- ORL
- RX
- Studies

12 min

Endometrial carcinoma, malignant melanoma and NSCLC in focus

Personalized mRNA and neoantigen vaccines in oncology

Input your search keywords and press Enter.